Skip to content

Clinical trials

Phase 2 Squamous Cell Carcinoma of Head and Neck trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2 Country / region: Taiwan Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20111
20121
20132
20153
20171
20192
20201
20214
20223
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated8
Active, not recruiting3
Recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Merck Sharp & Dohme LLC2
Pfizer2
SynCore Biotechnology Co., Ltd.2
AbbVie1
Ascendis Pharma A/S1
Bayer1
BeiGene1
Chang Gung Memorial Hospital1
China Medical University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck27
Head and Neck Neoplasms9
Esophageal Squamous Cell Carcinoma3
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Squamous Cell2
Melanoma2
Mouth Neoplasms2
Ovarian Neoplasms2
Recurrence2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.